ID

14004

Beschreibung

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01889407

Link

https://clinicaltrials.gov/show/NCT01889407

Stichworte

  1. 21.03.16 21.03.16 -
Hochgeladen am

21. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myeloid Leukemia NCT01889407

Eligibility Acute Myeloid Leukemia NCT01889407

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
Diagnosis of aml (who classification definition of >/= 20% blasts).
Beschreibung

AML

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
Patients aged 16 to 60 years are eligible. patients must be chemo-naïve, i.e. not have received any prior chemotherapy (except hydrea) for aml. they could have received transfusion, hematopoietic growth factors or vitamins. temporary measures such as pheresis or hydrea (0.5 to 5g daily or more for up to 3 days) are allowed.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
the relative expression level of mdr1 mrna (mdr1/gapdh ratio using the quantitative real-time pcr) in pre-treated bone marrow samples should over 0.016 (cut-off point from our results of preliminary experiment data)
Beschreibung

ABCB1 gene

Datentyp

boolean

Alias
UMLS CUI [1]
C0376622
ECOG performance status of 0, 1, 2 at screening
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Serum biochemical values with the following limits: - creatinine </= 2.0 mg/dl -
Beschreibung

Creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0010294
Total bilirubin </= 2.0 mg/dl, unless increase is due to hemolysis -
Beschreibung

Bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C0005437
Transaminases (sg pt) </= 3x uln
Beschreibung

Transaminases

Datentyp

boolean

Alias
UMLS CUI [1]
C0002594
Ability to understand and provide signed informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
Subjects with acute promyelocytic leukemia (apl)
Beschreibung

Acute Promyelocytic Leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0023487
Presence of active systemic infection
Beschreibung

Systemic infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0243026
Any coexisting medical condition that in the judgment of the treating physician is likely to interfere with study procedures or results.
Beschreibung

Medical condition

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0009488
Nursing women, women of childbearing potential with positive urine pregnancy test, or women of childbearing potential who are not willing to maintain adequate contraception (such as birth control pills, iud, diaphragm, abstinence, or condoms by their partner) over the entire course of the study.
Beschreibung

Positive urine pregnancy test

Datentyp

boolean

Alias
UMLS CUI [1]
C0430059

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT01889407

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
Diagnosis of aml (who classification definition of >/= 20% blasts).
boolean
C0023467 (UMLS CUI [1])
Age
Item
Patients aged 16 to 60 years are eligible. patients must be chemo-naïve, i.e. not have received any prior chemotherapy (except hydrea) for aml. they could have received transfusion, hematopoietic growth factors or vitamins. temporary measures such as pheresis or hydrea (0.5 to 5g daily or more for up to 3 days) are allowed.
boolean
C0001779 (UMLS CUI [1])
ABCB1 gene
Item
the relative expression level of mdr1 mrna (mdr1/gapdh ratio using the quantitative real-time pcr) in pre-treated bone marrow samples should over 0.016 (cut-off point from our results of preliminary experiment data)
boolean
C0376622 (UMLS CUI [1])
ECOG performance status
Item
ECOG performance status of 0, 1, 2 at screening
boolean
C1520224 (UMLS CUI [1])
Creatinine
Item
Serum biochemical values with the following limits: - creatinine </= 2.0 mg/dl -
boolean
C0010294 (UMLS CUI [1])
Bilirubin
Item
Total bilirubin </= 2.0 mg/dl, unless increase is due to hemolysis -
boolean
C0005437 (UMLS CUI [1])
Transaminases
Item
Transaminases (sg pt) </= 3x uln
boolean
C0002594 (UMLS CUI [1])
Informed Consent
Item
Ability to understand and provide signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Acute Promyelocytic Leukemia
Item
Subjects with acute promyelocytic leukemia (apl)
boolean
C0023487 (UMLS CUI [1])
Systemic infection
Item
Presence of active systemic infection
boolean
C0243026 (UMLS CUI [1])
Medical condition
Item
Any coexisting medical condition that in the judgment of the treating physician is likely to interfere with study procedures or results.
boolean
C0525058 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
Positive urine pregnancy test
Item
Nursing women, women of childbearing potential with positive urine pregnancy test, or women of childbearing potential who are not willing to maintain adequate contraception (such as birth control pills, iud, diaphragm, abstinence, or condoms by their partner) over the entire course of the study.
boolean
C0430059 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video